TDCS to Improve Post-Stroke Cognitive Impairment — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TDCS to Improve Post-Stroke Cognitive Impairment — Stella

Recruiting

Back to Stroke trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Johns Hopkins Bayview Medical Center, Baltimore, Maryland

Key details

Sponsor

Johns Hopkins University

Collaborators

University of Maryland, College Park, National Institutes of Health (NIH)

Enrollment target

~60 participants

Started

September 2022

Primary completion

August 2026

Age range

18 Years – 100 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov